CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • January 24th, 2024 • Orchard Therapeutics PLC • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJanuary 24th, 2024 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of December 15, 2023 (this “Agreement”), is entered into by and between Kyowa Kirin Co., Ltd., a Japanese joint stock company (kabushiki kaisha) (“Purchaser”), and Wilmington Savings Fund Society, FSB (the “Rights Agent”).